Pronóstico a largo plazo del uso no aprobado de stents liberadores de paclitaxel

The off-label use of PESs was associated with an increased risk of a combined clinical endpoint during long-term follow-up. Further studies are needed to determine the efficacy and safety of these devices in these settings.